We are live on ! Find out more
TNGX icon

Tango Therapeutics
TNGX

39 hedge funds and large institutions have $150M invested in Tango Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 6

12% more capital invested

Capital invested by funds: $135M → $150M (+$15.7M)

3% more funds holding

Funds holding: 38 → 39 (+1)

0.55% more ownership

Funds ownership: 63.33% → 63.87% (+0.55%)

67% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 9

Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
0.69%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
7
Increased
3
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$1.57M
2
DCM
Driehaus Capital Management
Illinois
+$273K
3
BFM
Boothbay Fund Management
New York
+$166K
4
ECM
ExodusPoint Capital Management
New York
+$105K
5
Wells Fargo
Wells Fargo
California
+$90.2K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$1.02M
2
CIM
Cowen Investment Management
New York
-$790K
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$461K
4
KSCM
Kamunting Street Capital Management
Florida
-$384K
5
PAMP
Polar Asset Management Partners
Ontario, Canada
-$259K
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$14.3M – – –
SCA
2
Southpoint Capital Advisors
New York
$9.72M – – –
ACA
3
Avoro Capital Advisors
New York
$9.15M – – –
BI
4
BVF Inc
California
$9.15M – – –
CAM
5
Cormorant Asset Management
Massachusetts
$9.15M – – –
EC
6
EcoR1 Capital
California
$9.15M – – –
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$6.86M – – –
BlackRock
8
BlackRock
New York
$6.86M – – –
RI
9
RTW Investments
New York
$6.86M – – –
WP
10
Woodline Partners
California
$5.76M +$35.8K +3,397 +0.7%
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$5.72M -$42.1K -4,000 -0.8%
BCLSI
12
Bain Capital Life Sciences Investors
Massachusetts
$5.72M – – –
PA
13
Perceptive Advisors
New York
$5.72M – – –
VA
14
VR Adviser
New York
$5.72M – – –
TCM
15
Tang Capital Management
California
$5.36M – – –
FCMV
16
Foresite Capital Management V
California
$4.58M +$4.21M +400,000 New
DCM
17
Driehaus Capital Management
Illinois
$3.73M +$273K +25,894 +9%
Citadel Advisors
18
Citadel Advisors
Florida
$3.69M -$188K -17,861 -5%
APM
19
Avidity Partners Management
Texas
$3.43M – – –
Millennium Management
20
Millennium Management
New York
$2.64M -$3.16K -300 -0.1%
LGM
21
Logos Global Management
California
$2.29M – – –
NCM
22
Nantahala Capital Management
Connecticut
$2.29M – – –
CCM
23
Consonance Capital Management
New York
$2.06M – – –
Janus Henderson Group
24
Janus Henderson Group
United Kingdom
$1.99M -$461K -43,747 -20%
TCM
25
Tenor Capital Management
New York
$1.72M – – –
1
2

TNGX Hedge Fund Activity: Q4 2020 in Review

39 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Tango Therapeutics (TNGX) for Q4 2020, worth a combined $150M — up 12% from $135M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TNGX positions and 6 closed out — a net gain of 1 holder — while 3 added to existing stakes and 9 trimmed.

The largest buyer was Ikarian Capital, adding an estimated $1.57M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $1.02M sold.

  • 39 institutional investors held Tango Therapeutics (TNGX) as of Q4 2020, up from 38 in Q3 2020.
  • Funds reported $150M of Tango Therapeutics stock for Q4 2020, up 12% quarter-over-quarter.
  • 7 funds opened new Tango Therapeutics positions in Q4 2020 and 6 closed out, a net change of +1 holder.
  • The largest Tango Therapeutics buyer in Q4 2020 was Ikarian Capital, an estimated $1.57M added.
  • The largest Tango Therapeutics seller in Q4 2020 was JP Morgan Chase, an estimated $1.02M sold.

Based on aggregated 13F filings for Q4 2020.